Related Experiment Video
Updated: Mar 16, 2026

Visualizing the Interrenal Steroidogenic Tissue and Its Vascular Microenvironment in Zebrafish
Published on: December 21, 2016
The urinary steroidome of treated children with classic 21-hydroxylase deficiency
Clemens Kamrath1, Lisa Wettstaedt1, Claudia Boettcher1
1Steroid Research & Mass Spectrometry Unit, Laboratory for Translational Hormone Analytics, Division of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany.
Insights
Monitoring classic congenital adrenal hyperplasia (CAH) in children is challenging. This study establishes urinary steroid metabolite reference ranges for treated 21-hydroxylase deficiency (21-OHD) patients, aiding clinical assessment and research.
Area of Science:
- Pediatric Endocrinology
- Metabolomics
- Genetics
Background:
- Classic congenital adrenal hyperplasia (CAH) management requires defined biochemical targets for effective treatment monitoring.
- Current monitoring strategies for children with CAH present significant challenges for clinicians.
- Established reference values for urinary steroid metabolites in treated pediatric CAH patients are lacking.
Purpose of the Study:
- To establish reference values for daily urinary steroid hormone metabolite excretion in children with classic 21-hydroxylase deficiency (21-OHD) undergoing treatment.
- To analyze growth and weight gain patterns in relation to treatment in pediatric CAH patients.
- To provide clinicians with tools for better classification of androgen, 17-hydroxyprogesterone (17-OHP), and glucocorticoid status.
Main Methods:
- Retrospective analysis of 576 daily urinary steroid hormone metabolite profiles.
- Gas chromatography-mass spectrometry (GC-MS) used for metabolite profiling.
- Study included 150 children aged 3.0-17.9 years with classic 21-OHD on hydrocortisone and fludrocortisone treatment.
Main Results:
- Children with classic CAH showed increased prepubertal height velocity followed by diminished pubertal growth, resulting in below-average final height.
- 11β-Hydroxyandrosterone was the predominant urinary androgen metabolite in CAH children; other androgens were suppressed under treatment.
- Glucocorticoid metabolites indicated supraphysiological hydrocortisone dosing, correlating with higher body-mass indices in treated children.
Conclusions:
- Established reference ranges for urinary steroid metabolites in treated pediatric CAH patients can aid clinical classification of endocrine status.
- Urinary 21-OHD-specific reference ranges are crucial for advancing research in pediatric CAH.
- The findings highlight the need for precise monitoring to optimize growth and metabolic control in children with CAH.
Abstract:
Monitoring treatment of children with classic congenital adrenal hyperplasia (CAH) is difficult and biochemical targets are not well defined. We retrospectively analysed 576 daily urinary steroid hormone metabolite profiles determined by gas chromatography-mass spectrometry of 150 children aged 3.0-17.9 years with classic 21-hydroxylase deficiency (21-OHD) on hydrocortisone and fludrocortisone treatment. Daily urinary excretion of glucocorticoid-, 17α-hydroxyprogesterone (17-OHP)-, and androgen metabolites as well as growth and weight gain are presented. Children with classic CAH exhibited increased height velocity during prepubertal age, which was then followed by diminished growth velocity during pubertal age until final height was reached. Final height was clearly below the population mean. 11β-Hydroxyandrosterone was the dominant urinary adrenal-derived androgen metabolite in CAH children. Adrenarche is blunted in children with CAH under hydrocortisone treatment and androgen metabolites except 11β-hydroxyandrosterone were suppressed. Cortisol metabolite excretion reflected supraphysiological hydrocortisone treatment dosage, which resulted in higher body-mass-indices in children with CAH. Reference values of daily urinary steroid metabolite excretions of treated children with CAH allow the clinician to adequately classify the individual patient regarding the androgen-, 17-OHP-, and glucocorticoid status in the context of the underlying disorder. Additionally, urinary 21-OHD-specific reference ranges will be important for research studies in children with CAH.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Renal Drug Excretion: Tubular Secretion
Urine Studies I: Urinalysis
Disorders of the Urinary System
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Serum Studies: Renal Function Tests

